Company Monitoring Page for Merck

job ratings for Merck

10/25/16
industry:
Big time pharma
job title:
Sales Rep
company:
Merck
job rating:
1
The job itself is boring and provides no value! It's so boring! Managers are a pain in the neck and I honestly can't handle another damn field visit with my manager.
06/29/16
industry:
pharmaceutical
job title:
Manager
company:
Merck
job rating:
1
Management is clueless. Employees are arrogant and self-centered. No new ideas are welcome.

Pages

latest headlines for company on cafepharma

Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
BioSpace
Tue, 02/27/24 - 10:18 am
Tags:
Merck, patents, Hikma, Bridion, muscle relaxants, generics
Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbuster
First Word Pharma
Thu, 02/22/24 - 11:43 am
Tags:
Samsung Bioepis, Merck, biosimilars, Keytruda, clinical trials
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive
Fri, 02/9/24 - 11:26 am
Tags:
Senate, drug pricing, Pharma CEOs, Bristol Myers Squibb, Chris Boerner, JNJ, Joaquin Duato, Merck, Rob Davis
PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US
Fierce Pharma
Thu, 02/8/24 - 10:08 pm
Tags:
Bernie Sanders, drug pricing, Pharma CEOs, Senate, Merck, Bristol Myers Squibb, JNJ, Rob Davis, Chris Boerner, Joaquin Duato
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
Motley Fool
Thu, 02/8/24 - 10:01 pm
Tags:
Merck, Eli Lilly, Novo Nordisk, weight loss
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices
Fierce Pharma
Tue, 02/6/24 - 11:33 pm
Tags:
Bernie Sanders, drug pricing, Merck, JNJ, Bristol Myers Squibb, Pharma CEOs
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
Tags:
oncology, cancer, Keytruda, Revlimid, Opdivo, Imbruvica, Darzalex, Merck, Bristol Myers Squibb, AbbVie, Janssen
Merck still in the market for deals in the $1B to $15B range, CEO says
Fierce Pharma
Thu, 02/1/24 - 10:56 pm
Tags:
Merck, M&A, Pharma CEOs, Rob Davis, Prometheus Biosciences
Merck seeks more deals to prepare for Keytruda's revenue decline
Yahoo/Reuters
Thu, 02/1/24 - 11:24 am
Tags:
Merck, earnings, Keytruda
Merck inks research deal with Culmination Bio to leverage ‘powerful’ patient data platform
Biopharma Reporter
Tue, 01/30/24 - 10:32 am
Tags:
Merck, Culmination Bio, Intermountain Health, R&D
J&J, Merck CEOs to testify at Senate panel after Sanders’ subpoena threats
Medical Marketing and Media
Mon, 01/29/24 - 10:32 pm
Tags:
JNJ, Merck, Pharma CEOs, Joaquin Duato, Robert Davis, Senate, drug pricing, Bernie Sanders
After Padcev combo’s major triumph, Merck’s Keytruda delivers partial win in bladder cancer
Fierce Pharma
Fri, 01/26/24 - 12:03 pm
Tags:
Merck, Keytruda, bladder cancer
Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says
Stat
Thu, 01/25/24 - 09:14 pm
Tags:
drug pricing, Bernie Sanders, Pharma CEOs, Merck, Robert Davis
Merck finds drug discovery DALL-E, becoming early user of small molecule generative AI tool
Fierce Biotech
Thu, 01/25/24 - 10:49 am
Tags:
Merck, drug discovery, artificial intelligence, generative AI, Variational AI, small molecule drugs
Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’
Fierce Biotech
Tue, 01/23/24 - 11:00 am
Tags:
Merck, macrocycle drugs, drug discovery, Unnatural Products
Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
Stat
Thu, 01/18/24 - 04:58 pm
Tags:
Bernie Sanders, drug pricing, Pharma CEOs, JNJ, Merck
Merck (MRK) Keytruda Ok'd by FDA for Expanded Cervical Cancer Use
Yahoo/Zacks.com
Tue, 01/16/24 - 09:46 am
Tags:
Merck, cervical cancer, Keytruda, FDA
7 JPM Announcements You Don’t Want to Miss
MedCity News
Fri, 01/12/24 - 09:51 am
Tags:
JPMHC 2024, Boston Scientfic, M&A, Axonics, Amazon, JNJ, Mayo Clinic, artificial intelligence, diabetes, Abbott Labs, Innovaccer, Merck
JPM24: Merck expects $20B+ in new cancer sales thanks to Daiichi ADC deal, Moderna vaccine
Fierce Pharma
Tue, 01/9/24 - 10:44 am
Tags:
Merck, JPMHC 2024, Pharma CEOs, Robert Davis
Merck inks $680M Harpoon buyout, spearing challenger to Amgen T-cell engager
Fierce Biotech
Mon, 01/8/24 - 11:36 am
Tags:
Merck, Harpoon Therapeutics, M&A, T-cell engager, JPMHC 2024

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.